These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies. Lopate G; Choksi R; Pestronk A Muscle Nerve; 2002 Jun; 25(6):828-36. PubMed ID: 12115971 [TBL] [Abstract][Full Text] [Related]
5. Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg). van Schaik IN; Vermeulen M; van Doorn PA; Brand A J Neuroimmunol; 1994 Oct; 54(1-2):109-15. PubMed ID: 7929799 [TBL] [Abstract][Full Text] [Related]
6. High anti-GM1 and anti-GD1a IgG antibody titers are detected in Guillain-Barré syndrome but not in chronic inflammatory demyelinating polyneuropathy. Tagawa Y; Yuki N; Hirata K Eur Neurol; 2002; 48(2):118-9. PubMed ID: 12187004 [No Abstract] [Full Text] [Related]
7. Demyelinating symmetric motor polyneuropathy with high anti-GM1 antibody titer: do we need to split? Galassi G Muscle Nerve; 2011 Jul; 44(1):147-8; author reply 148. PubMed ID: 21660986 [No Abstract] [Full Text] [Related]
8. Serum antibodies to heparan sulfate glycosaminoglycans in Guillain-Barré syndrome and other demyelinating polyneuropathies. Pestronk A; Choksi R; Yee WC; Kornberg AJ; Lopate G; Trotter J J Neuroimmunol; 1998 Nov; 91(1-2):204-9. PubMed ID: 9846837 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory polyneuropathy after heart transplantation. Its association with antibodies to asialo-GM1 and sulfatide. Adair J; Rose J; Alderson K Transplantation; 1993 Dec; 56(6):1597-9. PubMed ID: 8305086 [No Abstract] [Full Text] [Related]
11. Delayed appearance of anti-myelin-associated glycoprotein antibodies in a patient with chronic demyelinating polyneuropathy. Valldeoriola F; Graus F; Steck AJ; Muñoz E; de la Fuente M; Gallart T; Ribalta T; Bombí JA; Tolosa E Ann Neurol; 1993 Sep; 34(3):394-6. PubMed ID: 7689821 [TBL] [Abstract][Full Text] [Related]
12. Three different anti-myelin antibodies in a case of demyelinating dysglobulinemic peripheral neuropathy. Ellie E; Younes-Chennoufi AB; Couto A; Vital A; Hilmi S; Demotes-Mainard J; Baumann N; Petry KG J Peripher Nerv Syst; 1997; 2(1):43-8. PubMed ID: 10975735 [TBL] [Abstract][Full Text] [Related]
16. Acute motor axonal neuropathy after Mycoplasma infection: Evidence of molecular mimicry. Susuki K; Odaka M; Mori M; Hirata K; Yuki N Neurology; 2004 Mar; 62(6):949-56. PubMed ID: 15037698 [TBL] [Abstract][Full Text] [Related]
17. Demyelinating symmetric motor polyneuropathy with high titers of anti-GM1 antibodies. O'Ferrall EK; White CM; Zochodne DW Muscle Nerve; 2010 Oct; 42(4):604-8. PubMed ID: 20730877 [TBL] [Abstract][Full Text] [Related]
19. [Antibodies to GM1 ganglioside in motor neuron disease--in comparison with demyelinating neuropathy]. Irie S; Saito T; Ogino M; Ito H; Kowa H Rinsho Shinkeigaku; 1992 Oct; 32(10):1075-80. PubMed ID: 1297550 [TBL] [Abstract][Full Text] [Related]
20. Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy. Dalakas MC; Rakocevic G; Salajegheh M; Dambrosia JM; Hahn AF; Raju R; McElroy B Ann Neurol; 2009 Mar; 65(3):286-93. PubMed ID: 19334068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]